Mizuho’s Jared Holz on how to play the underperforming health care sector
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Jared Holz, Mizuho Securities healthcare sector strategist, joins ‘The Exchange’ to discuss Insmed’s lung drug being greenlit by the FDA and his read on the healthcare sector. 04:38 Thu, Aug 14 20251:38 PM EDT Source link